Nsaid-associated Gastric Ulcers
📧 Sign up to get email alerts when something new happens for Nsaid-associated Gastric Ulcers.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium submitted by Eugia US LLC.
-
FDA approval · 2023-10-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium from Mylan Pharmaceuticals, making a generic version of the proton pump i…
-
FDA approval · 2023-03-08FDA Approved: ESOMEPRAZOLE SODIUM — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for esomeprazole sodium from Gland Pharma Limited, expanding the generic's regulatory approval. The …
-
FDA approval · 2020-12-01FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for generic omeprazole from Lannett Company under ANDA075410, authorizing continued marketing under …
-
FDA approval · 2020-06-02FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Allegiant Health)
FDA approved Allegiant Health's esomeprazole magnesium delayed-release capsule as an original ANDA, providing a generic proton pump inhibito…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-08-10FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original application for esomeprazole sodium, a generic proton pump inhibitor, confirming a generic version of t…
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.